Skip to main content
Figure 3 | Malaria Journal

Figure 3

From: Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting

Figure 3

Number of adverse events (AEs) reported per month during 1st September 2007 to 31st March 2010 indicated on the left-hand y-axis. The right-hand y-axis indicates the percentage of AL tablets prescribed per month, with the total number of AL tablets during 1st September 2007 to 31st March 2010 as the denominator.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us